| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2007 | CA2631231A1 Therapeutic agent for corneal/conjuctival disease |
| 06/14/2007 | CA2631128A1 Tricyclic amide derivatives useful for treating obesity |
| 06/14/2007 | CA2631037A1 Bradykinin 1 receptor antagonists |
| 06/14/2007 | CA2631007A1 1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as ptp-as inhibitors |
| 06/14/2007 | CA2630904A1 Compositions and methods for therapy and diagnosis of cancer |
| 06/14/2007 | CA2630784A1 Process for the preparation of purified crystalline cci-779 |
| 06/14/2007 | CA2630666A1 Jasmonate derivatives, pharmaceutical compositions and methods of use thereof |
| 06/14/2007 | CA2630624A1 Compositions and methods for increasing insulin sensitivity |
| 06/14/2007 | CA2630611A1 Aryl acetic acid and ester derivatives and their uses as antiinflammatory |
| 06/14/2007 | CA2630595A1 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 06/14/2007 | CA2630553A1 Estrogen cancer therapy |
| 06/14/2007 | CA2630517A1 Morpholine carboxamide prokineticin receptor antagonists |
| 06/14/2007 | CA2630500A1 Matrix-controlled transdermal system comprising salts of ace inhibitor dicarboxylic acids |
| 06/14/2007 | CA2630492A1 Spiro-lactam compounds |
| 06/14/2007 | CA2630468A1 Medicinal drug |
| 06/14/2007 | CA2630458A1 Benzimidazole non-aqueous compositions |
| 06/14/2007 | CA2630448A1 1,1,3-trioxo-1,2,5-thiadiazolidines and their use as ptp-ases inhibitors |
| 06/14/2007 | CA2630417A1 Quinazolinone derivatives as vanilloid antagonists |
| 06/14/2007 | CA2630233A1 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors |
| 06/14/2007 | CA2629915A1 Isoquinoline derivatives |
| 06/14/2007 | CA2629913A1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
| 06/14/2007 | CA2629857A1 Thiadiazole derivatives as antidiabetic agents |
| 06/14/2007 | CA2629819A1 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase) |
| 06/14/2007 | CA2629747A1 Bicyclic heteroyclic compounds as antiinflammatory agents |
| 06/14/2007 | CA2629743A1 Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors |
| 06/14/2007 | CA2629740A1 Zolpidem tablets |
| 06/14/2007 | CA2629608A1 Chromone derivatives useful as antagonists of vr1 receptors |
| 06/14/2007 | CA2629137A1 Bis-heterocyclic imidazolyl compounds |
| 06/14/2007 | CA2629132A1 Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis |
| 06/14/2007 | CA2628582A1 Biocompatible tissue sealants and adhesives |
| 06/14/2007 | CA2628579A1 Carbodiimide crosslinking of functionalized polethylene glycols |
| 06/14/2007 | CA2628575A1 Biocompatible surgical compositions |
| 06/14/2007 | CA2625338A1 Salts of fatty acids and methods of making and using thereof |
| 06/14/2007 | CA2621866A1 Stable solid formulation of sertindole |
| 06/14/2007 | CA2621854A1 Pyrimidine derivatives and their use as kcnq potassium channels openers |
| 06/13/2007 | EP1795603A1 Process for synthesis of derivatives, compound library, method for making the mase, and screening method |
| 06/13/2007 | EP1795596A1 Composition and methods for therapy and diagnosis of cancer |
| 06/13/2007 | EP1795593A1 Target nucleic acid of retrovirus integration |
| 06/13/2007 | EP1795531A1 A thiazolidinedione derivative and its use as antidiabetic |
| 06/13/2007 | EP1795527A1 Carbamoyl-substituted spiro derivative |
| 06/13/2007 | EP1795526A1 N-substituted n-(4-piperidinyl)amide derivative |
| 06/13/2007 | EP1795524A1 Cyclic amine derivative or salt thereof |
| 06/13/2007 | EP1795213A2 Implantable microbial cellulose materials for various medical applications |
| 06/13/2007 | EP1795207A1 Solid pharmaceutical preparation |
| 06/13/2007 | EP1795206A1 Drug for treating or preventing hcv infection |
| 06/13/2007 | EP1795203A2 Fhit proteins and nucleic acids and methods based thereon |
| 06/13/2007 | EP1795201A1 Isolation of oleuropein from the leaves of olive tree |
| 06/13/2007 | EP1795200A1 Medicine and food/beverage for ameliorating hyperglycemia |
| 06/13/2007 | EP1795199A2 Quetiapine for the treatment of substance dependence or substance abuse |
| 06/13/2007 | EP1795198A1 Treatment of Barret's esophagus |
| 06/13/2007 | EP1795197A1 Pharmaceutical compositions comprising an antibiotic |
| 06/13/2007 | EP1795196A2 Method of treating lower urinary tract disorders |
| 06/13/2007 | EP1795195A1 New prazole compound and the use thereof |
| 06/13/2007 | EP1795194A2 Use of an antagonist of CB1 receivers associated with a beta3-agonist for preparing medication to be used for treating appetence |
| 06/13/2007 | EP1795193A1 Suppressant for cerebral infarction attributed to long-time ischemia |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1795191A1 Oral pharmaceutical for dry skin prevention or remedy |
| 06/13/2007 | EP1795190A1 Agent for suppressing body fat accumulation |
| 06/13/2007 | EP1795189A2 Method of administering buprenorphine to treat depression |
| 06/13/2007 | EP1795182A1 Liposome improving intracellular drug delivery |
| 06/13/2007 | EP1795181A1 Cosmetic and pharmaceutical uses of the dipeptide tyrosine-arginine in combination with niacinamide as substance P antagonist |
| 06/13/2007 | EP1794313A2 Screening methods using c-abl, fyn and syk in combination with tau protein |
| 06/13/2007 | EP1794195A2 Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof |
| 06/13/2007 | EP1794176A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 06/13/2007 | EP1794174A2 Methods and compositions for inhibition of innate immune responses and autoimmunity |
| 06/13/2007 | EP1794172A1 Antiviral 4'-azido-nucleosides |
| 06/13/2007 | EP1794167A1 Substituted isoxazoles as fungicides |
| 06/13/2007 | EP1794164A2 Bridged piperazine and piperidine derivatives as ccr1 antagonists |
| 06/13/2007 | EP1794162A1 Purine derivatives as a3 and a1 adenosine receptor agonists |
| 06/13/2007 | EP1794160A1 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors |
| 06/13/2007 | EP1794159A1 7-azaindoles and their use as ppar agonists |
| 06/13/2007 | EP1794157A1 2-acylaminothiazole derivatives |
| 06/13/2007 | EP1794155A1 Oxazole derivatives as her tyrosine kinase inhibitors |
| 06/13/2007 | EP1794154A1 Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases |
| 06/13/2007 | EP1794153A1 1,2,3-triazole derivatives as receptor tyrosine kinase inhibitors |
| 06/13/2007 | EP1794152A1 Method for manufacturing enantiomeric imidazole compounds |
| 06/13/2007 | EP1794151A1 Dna-pk inhibitors |
| 06/13/2007 | EP1794150A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands I |
| 06/13/2007 | EP1794149A2 Bicyclic amides as kinase inhibitors |
| 06/13/2007 | EP1794148A1 Novel phthalazinone derivatives, as aurora-a kinase inhibitors |
| 06/13/2007 | EP1794147A1 Compounds |
| 06/13/2007 | EP1794146A2 Tricyclic anilide spirohydantoin cgrp receptor antagonists |
| 06/13/2007 | EP1794145A1 Pyrazole compounds useful in the treatment of inflammation |
| 06/13/2007 | EP1794143A1 Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
| 06/13/2007 | EP1794142A1 A novel compound and a novel microorganism for producing the novel compound |
| 06/13/2007 | EP1794141A1 Substituted chroman derivatives, medicaments and use in therapy |
| 06/13/2007 | EP1794137A2 Specific kinase inhibitors |
| 06/13/2007 | EP1794135A1 Substituted heterocyclic compounds and methods of use |
| 06/13/2007 | EP1794134A1 Substituted 2-anilinopyrimidines as cell cycle kinase inhibitors or receptor tyrosine kinase inhibitors, production of said substances and use of the latter as medicaments |
| 06/13/2007 | EP1794133A2 Aryl spirolactam cgrp receptor antagonists |
| 06/13/2007 | EP1794132A2 Process for production of 2-chloro-4-nitroimidazole |
| 06/13/2007 | EP1794130A1 Pyrazole compounds useful in the treatment of inflammation |
| 06/13/2007 | EP1794128A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them |
| 06/13/2007 | EP1794126A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 06/13/2007 | EP1794125A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 06/13/2007 | EP1794123A1 3-spiro-indolin-2-one derivatives as vasopressin receptor ligand |
| 06/13/2007 | EP1794122A1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
| 06/13/2007 | EP1794121A1 Novel crystalline form of (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)-piperazine-1-yl]-methanone hydrochloride |
| 06/13/2007 | EP1794120A2 Peptidase inhibitors |
| 06/13/2007 | EP1794116A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |